Consecutive patients with active cancer and proximal deep-vein thrombosis or pulmonary embolism who had completed ... in a 1:1 ratio to receive oral apixaban at a reduced (2.5 mg) or full (5.0 ...

Purpose The pharmacology, pharmacokinetics, efficacy, and safety of apixaban are reviewed. Summary Apixaban is an oral, direct, selective factor Xa inhibitor with a rapid onset of action.

Bristol Myers Squibb reported third-quarter earnings and revenue that blew past expectations on strong sales from its blood thinner Eliquis and a portfolio of drugs it expects to deliver long-term ...